Metabolism and action of amino acid analog anti-cancer agents

Pharmacology & Therapeutics
G S AhluwaliaD A Cooney

Abstract

The preclinical pharmacology, antitumor activity and toxicity of seven of the more important amino acid analogs, with antineoplastic activity, is discussed in this review. Three of these compounds are antagonists of L-glutamine: acivicin, DON and azaserine; and two are analogs of L-aspartic acid: PALA and L-alanosine. All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell. The remaining two compounds, buthionine sulfoximine and difluoromethylornithine, are inhibitors of glutathione and polyamine synthesis, respectively, with limited intrinsic antitumor activity; however, because of their powerful biochemical actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.

References

Jul 15, 1976·Biochemical Pharmacology·H N JayaramR J Rosenbluth
Aug 15, 1976·Biochemical Pharmacology·R J RosenbluthE R Homan
Aug 15, 1976·Biochemical Pharmacology·D A CooneyR J Rosenbluth
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·O W Griffith, A Meister
Apr 6, 1978·Biochimica Et Biophysica Acta·J JänneA Raina
Dec 15, 1979·Biochemical Pharmacology·H N JayaramD A Cooney
Jan 1, 1978·Advances in Enzyme Regulation·R K BoutwellE G Astrup
Jan 1, 1985·Advances in Enzyme Regulation·N Prajda
Jan 1, 1985·Teratogenesis, Carcinogenesis, and Mutagenesis·P E Mirkes
Dec 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T R BurokerJ A Laurie
Mar 1, 1986·The Biochemical Journal·A E Pegg
Aug 15, 1986·International Journal of Cancer. Journal International Du Cancer·D M OtaK Nishioka
Jun 1, 1986·European Journal of Cancer & Clinical Oncology·M TalpazJ Gutterman
Jul 1, 1986·European Journal of Cancer & Clinical Oncology·D M OtaD Dixon
Jan 1, 1987·Investigational New Drugs·C A GriffinM D Abeloff
Jan 1, 1988·Cancer Chemotherapy and Pharmacology·M P SullivanB Van Nguyen
May 15, 1988·International Journal of Cancer. Journal International Du Cancer·K R HuberJ Roberts
Jul 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R F MortonM Chang
Jun 1, 1986·American Journal of Clinical Oncology·C C AdolphsonA Y Bedikian
Sep 1, 1986·International Journal of Radiation Oncology, Biology, Physics·K OnoM Abe
Jan 1, 1987·Cancer Chemotherapy and Pharmacology·M MarkmanS B Howell
Jan 1, 1985·Investigational New Drugs·A M MaddoxE J Freireich
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·G GallianiG C Lancini
Jun 1, 1985·Archives of Biochemistry and Biophysics·M E AndersonA Meister
Dec 15, 1974·Biochemical Pharmacology·D A CooneyR Fleischman
Jan 1, 1970·Advances in Enzyme Regulation·M J SweeneyG A Poore

❮ Previous
Next ❯

Citations

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·P M PolitiJ M Hamilton
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F WuB Långström
Jul 12, 2012·Nature Biotechnology·Heesun CheongCraig B Thompson
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·A HoferL Thelander
Feb 11, 2009·The Journal of Biological Chemistry·Jarrod B KingMarie H Hanigan
Dec 1, 1993·Annals of Surgery·W W Souba
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Catherine Z ChenWei Zheng
Sep 4, 2013·The Journal of Clinical Investigation·Christopher T HensleyRalph J DeBerardinis
Sep 22, 2012·Disease Models & Mechanisms·Lee F WilloughbyAnthony M Brumby
Jan 7, 2014·Trends in Biochemical Sciences·Kirsten L BryantChanning J Der
Jan 16, 2014·Annual Review of Medicine·Ekaterina Bobrovnikova-Marjon, Jonathan B Hurov
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Matthew C T HartmanJack W Szostak
Sep 21, 2013·Future Medicinal Chemistry·Michael J LukeyRichard A Cerione
Oct 15, 2013·Nature Chemical Biology·Soumaya ZlitniEric D Brown
Aug 2, 2011·Chinese Journal of Cancer·Naima HammoudiPeng Huang
Mar 31, 2015·International Journal of Cancer. Journal International Du Cancer·Mohamed HassaneinPierre P Massion
Feb 11, 2015·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Marcel CetindisMartin Grimm
Dec 31, 2014·Proceedings of the National Academy of Sciences of the United States of America·Clint A StalneckerJon W Erickson
Dec 5, 2012·Current Opinion in Biotechnology·Karsten Hiller, Christian M Metallo
Jun 24, 2010·Trends in Biochemical Sciences·David R Wise, Craig B Thompson
Dec 25, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Humberto De VittoJames A Radosevich
Apr 5, 2008·Current Opinion in Genetics & Development·Ralph J DeberardinisCraig B Thompson
May 21, 2016·ACS Medicinal Chemistry Letters·Sarah C ZimmermannTakashi Tsukamoto
Aug 27, 2014·International Journal of Cancer. Journal International Du Cancer·Jan BudcziesCarsten Denkert
Oct 11, 2015·Seminars in Cancer Biology·Matthew D HirscheyUNKNOWN Target Validation Team
Nov 26, 2015·Oncogene·L JinS Kang
Oct 2, 2015·BioMed Research International·Diana Cervantes-MadridAlfonso Dueñas-González
Sep 3, 2014·Mitochondrion·Björn KruspigVladimir Gogvadze
Aug 26, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Stephanie WickhamMarie H Hanigan
Jul 20, 2014·Biochimica Et Biophysica Acta·Therese Wahlström, Marie Arsenian Henriksson
Nov 17, 2012·Cancer Cell·Guoliang QingM Celeste Simon
Jan 30, 2015·Nutrition and Cancer·Amalia PapanikolopoulouNikolaos Drakoulis
Apr 21, 2016·Cancers·Daniel ZeitouniKirsten L Bryant
Aug 23, 2016·The Journal of Clinical Investigation·Thomas BerteroStephen Y Chan
Dec 1, 2006·Advances in Parasitology·Michael P Barrett, Ian H Gilbert
Jul 4, 2007·The Journal of Cell Biology·Mariia YunevaYuri Lazebnik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.